In the current review, we focus on the contribution of select neuropeptides in three distinct airway diseases: asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis
10.1093/oxfordjournals.bmb.a072641 92 RantforsJ.CassutoJ
Some FDA-approved peptide medications have proven their value for supporting health after rigorous testing, clinical research, and real-world use
COPD In COPD, it has been reported that NPY expression is decreased in the lung epithelium, glands and smooth muscle tissue [171], and the authors speculated that such changes might contribute to COPD pathogenesis
I mean, I have patients come in and they will haul in all their supplements and it's DR ROSSI: Oh, you don't want to see my cabinet